FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mitchell Brin

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Living Beings

Jews

Procedures

Anatomy

Chromosomes, Human, Pair 9

Genes & Molecular Sequences

Dominant Genes

Co-author Network

Publications

TOP 3
David A Ginsberg; Angelo Gousse; Mitchell F Brin; Brenda Jenkins; Veronique Keppenne; Wayne Lam; Karl-Dietrich Sievert; Catherine Thompson; Cornelia Haag-Molkenteller
Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.
Nutan Sharma; Ramon A Franco; John K Kuster; Adele A Mitchell; Tania Fuchs; Rachel Saunders-Pullman; Deborah Raymond; Mitchell F Brin; Andrew Blitzer; Susan Bressman; Laurie J Ozelius
Genetic evidence for an association of the TOR1A locus with segmental/focal dystonia.
Mitchell F Brin; Cynthia L Comella; Joseph Jankovic; Francis Lai; Markus Naumann
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mitchell Brin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: David A Ginsberg; Angelo Gousse; Mitchell F Brin; Brenda Jenkins; Veronique Keppenne; Wayne Lam; Karl-Dietrich Sievert; Catherine Thompson; Cornelia Haag-Molkenteller
Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.
The Journal of urology 2012;187(6):2131-9.
2010: Nutan Sharma; Ramon A Franco; John K Kuster; Adele A Mitchell; Tania Fuchs; Rachel Saunders-Pullman; Deborah Raymond; Mitchell F Brin; Andrew Blitzer; Susan Bressman; Laurie J Ozelius
Genetic evidence for an association of the TOR1A locus with segmental/focal dystonia.
Movement disorders : official journal of the Movement Disorder Society 2010;25(13):2183-7.
2008: Mitchell F Brin; Cynthia L Comella; Joseph Jankovic; Francis Lai; Markus Naumann
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
Movement disorders : official journal of the Movement Disorder Society 2008;23(10):1353-60.
2008: Deborah Raymond; Rachel Saunders-Pullman; Patricia de Carvalho Aguiar; Birgitt Schule; Norman Kock; Jennifer Friedman; Juliette Harris; Blair Ford; Steven Frucht; Gary A Heiman; Danna Jennings; Dana Doheny; Mitchell F Brin; Deborah de Leon Brin; Trisha Multhaupt-Buell; Anthony E Lang; Roger Kurlan; Christine Klein; Laurie J Ozelius; Susan Bressman
Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations.
Movement disorders : official journal of the Movement Disorder Society 2008;23(4):588-92.
2007: Stuart A Yablon; Allison Brashear; Mark Forrest Gordon; Elie P Elovic; Catherine C Turkel; Simon Daggett; Jingyu Liu; Mitchell F Brin
Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
Clinical therapeutics 2007;29(4):683-90.
2006: Catherine C Turkel; Beta Bowen; Jingyu Liu; Mitchell F Brin
Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
Archives of physical medicine and rehabilitation 2006;87(6):786-92.
2005: Pullanipally Shashidharan; Daniela Sandu; U Potla; I A Armata; Ruth H Walker; Kevin St P McNaught; Donald Weisz; T Sreenath; Mitchell F Brin; C Warren Olanow
Transgenic mouse model of early-onset DYT1 dystonia.
Human molecular genetics 2005;14(1):125-33.
2004: Rachel Saunders-Pullman; N Blau; Keith Hyland; J Zschocke; TG Nygaard; Deborah Raymond; Vicki Shanker; Kathrin Mohrmann; L Arnold; SD Tabbal; D DeLeon; Blair Ford; Mitchell F Brin; S Chouinard; Laurie J Ozelius; Christine Klein; Susan Bressman
Phenylalanine loading as a diagnostic test for DRD: interpreting the utility of the test.
Molecular genetics and metabolism 2004;83(3):207-12.
2004: Chris E Morrison; Joan C Borod; Mitchell F Brin; T D Hälbig; C Warren Olanow
Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD).
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(10-11):1333-41.
2004: Colum D MacKinnon; Miodrag Velickovic; Cristina Drafta; Alexander Hesquijarosa; Mitchell F Brin
Corticospinal excitability accompanying ballistic wrist movements in primary dystonia.
Movement disorders : official journal of the Movement Disorder Society 2004;19(3):273-84.
2004: Chris E Morrison; Joan C Borod; Kenneth Perrine; Aleksandar Beric; Mitchell F Brin; Ali R Rezai; P Kelly; Djordje Sterio; Isabelle M Germano; Donald Weisz; C Warren Olanow
Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 2004;19(2):165-81.
2003: C Warren Olanow; Christopher G Goetz; Jeffrey Kordower; A Jon Stoessl; Vesna Sossi; Mitchell F Brin; Kathleen M Shannon; G Michael Nauert; Daniel P Perl; James Godbold; Thomas B Freeman
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
Annals of neurology 2003;54(3):403-14.
2003: David K Simon; Jennifer Friedman; Xandra O Breakefield; Joseph Jankovic; Mitchell F Brin; John Provias; Susan Bressman; Michael E Charness; Daniel Tarsy; Donald R Johns; Mark A Tarnopolsky
A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia.
Neurogenetics 2003;4(4):199-205.
2003: Lucian Sulica; Andrew Blitzer; Mitchell F Brin; Celia F Stewart
Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
The Annals of otology, rhinology, and laryngology 2003;112(6):499-505.
2002: Christine Klein; Liu Liu; Dana Doheny; Norman Kock; Birgitt Müller; Patricia de Carvalho Aguiar; Joanne Leung; Deborah de Leon; Susan Bressman; Jeremy Silverman; Christopher Smith; Fabio Danisi; Chris Morrison; Ruth H Walker; Miodrag Velickovic; Eberhard Schwinger; Patricia L Kramer; Xandra O Breakefield; Mitchell F Brin; Laurie J Ozelius
Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations.
Annals of neurology 2002;52(5):675-9.
2002: Dana Doheny; Fabio Danisi; Christopher Smith; C Morrison; Miodrag Velickovic; Deborah de Leon; Susan Bressman; Joanne Leung; Laurie J Ozelius; Christine Klein; Xandra O Breakefield; Mitchell F Brin; Jeremy Silverman
Clinical findings of a myoclonus-dystonia family with two distinct mutations.
Neurology 2002;59(8):1244-6.
2002: Dana Doheny; Mitchell F Brin; Chris E Morrison; C J Smith; Ruth H Walker; S Abbasi; Birgitt Müller; Jennifer Garrels; Liu Liu; Patricia de Carvalho Aguiar; Karla Schilling; Patricia L Kramer; Deborah de Leon; Deborah Raymond; Rachel Saunders-Pullman; Christine Klein; Susan Bressman; B Schmand; Marina A J Tijssen; Laurie J Ozelius; Jeremy Silverman
Phenotypic features of myoclonus-dystonia in three kindreds.
Neurology 2002;59(8):1187-96.
2002: William J Binder; Mitchell F Brin; Andrew Blitzer; Janice M Pogoda
Botulinum toxin type A (BOTOX) for treatment of migraine.
Disease-a-month : DM 2002;48(5):323-35.
2002: Ruth H Walker; Dushyant P Purohit; Paul F Good; Daniel P Perl; Mitchell F Brin
Severe generalized dystonia due to primary putaminal degeneration: case report and review of the literature.
Movement disorders : official journal of the Movement Disorder Society 2002;17(3):576-84.
2002: Ruth H Walker; S Morgello; B Davidoff-Feldman; A Melnick; M J Walsh; Pullanipally Shashidharan; Mitchell F Brin
Autosomal dominant chorea-acanthocytosis with polyglutamine-containing neuronal inclusions.
Neurology 2002;58(7):1031-7.
2002: Ruth H Walker; Mitchell F Brin; Daniela Sandu; Paul F Good; Pullanipally Shashidharan
TorsinA immunoreactivity in brains of patients with DYT1 and non-DYT1 dystonia.
Neurology 2002;58(1):120-4.
2001: J C Leung; Christine Klein; Jennifer Friedman; Peter Vieregge; H Jacobs; Dana Doheny; Christoph Kamm; D DeLeon; Peter P Pramstaller; John B Penney; M Eisengart; Joseph Jankovic; T Gasser; Susan Bressman; David P Corey; Patricia L Kramer; Mitchell F Brin; Laurie J Ozelius; Xandra O Breakefield
Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism.
Neurogenetics 2001;3(3):133-43.
2001: Mitchell F Brin; Kelly E Lyons; J Doucette; Charles H Adler; John Caviness; Cynthia L Comella; R M Dubinsky; Joseph H Friedman; B V Manyam; J Y Matsumoto; Seth L Pullman; Ali H Rajput; Kapil D Sethi; Caroline M Tanner; William Koller
A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.
Neurology 2001;56(11):1523-8.
2001: William J Binder; Mitchell F Brin; Andrew Blitzer; Janice M Pogoda
Botulinum toxin type A (BOTOX) for treatment of migraine.
Seminars in cutaneous medicine and surgery 2001;20(2):93-100.
2001: J Verheyden; Andrew Blitzer; Mitchell F Brin
Other noncosmetic uses of BOTOX.
Seminars in cutaneous medicine and surgery 2001;20(2):121-6.
2001: Ruth H Walker; Mitchell F Brin; Daniela Sandu; P Gujjari; Patrick R Hof; C Warren Olanow; Pullanipally Shashidharan
Distribution and immunohistochemical characterization of torsinA immunoreactivity in rat brain.
Brain research 2001;900(2):348-54.
2001: Miodrag Velickovic; R Benabou; Mitchell F Brin
Cervical dystonia pathophysiology and treatment options.
Drugs 2001;61(13):1921-43.
2001: C Warren Olanow; Mitchell F Brin
Surgical therapies for Parkinson's disease. A physician's perspective.
Advances in neurology 2001;86():421-33.
2000: William J Binder; Mitchell F Brin; Andrew Blitzer; L D Schoenrock; Janice M Pogoda
Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2000;123(6):669-76.
2000: Ruth H Walker; Fabio Danisi; D M Swope; Robert R Goodman; Isabelle M Germano; Mitchell F Brin
Intrathecal baclofen for dystonia: benefits and complications during six years of experience.
Movement disorders : official journal of the Movement Disorder Society 2000;15(6):1242-7.
2000: Christine Klein; Karla Schilling; Rachel Saunders-Pullman; Jennifer Garrels; Xandra O Breakefield; Mitchell F Brin; D DeLeon; Dana Doheny; Stanley Fahn; J S Fink; Lars Forsgren; Jennifer Friedman; S Frucht; Juliette Harris; Gösta Holmgren; Bernhard Kis; Roger Kurlan; M Kyllerman; Anthony E Lang; Joanne Leung; Deborah Raymond; J D Robishaw; G Sanner; Eberhard Schwinger; Rowena Tabamo; Michele Tagliati
A major locus for myoclonus-dystonia maps to chromosome 7q in eight families.
American journal of human genetics 2000;67(5):1314-9.
2000: Pullanipally Shashidharan; Paul F Good; Amy Hsu; Daniel P Perl; Mitchell F Brin; C Warren Olanow
TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.
Brain research 2000;877(2):379-81.
2000: Chris E Morrison; Joan C Borod; Mitchell F Brin; S A Raskin; Isabelle M Germano; Donald Weisz; C Warren Olanow
A program for neuropsychological investigation of deep brain stimulation (PNIDBS) in movement disorder patients: development, feasibility, and preliminary data.
Neuropsychiatry, neuropsychology, and behavioral neurology 2000;13(3):204-19.
2000: Susan Bressman; C Sabatti; Deborah Raymond; Deborah de Leon; Christine Klein; Patricia L Kramer; Mitchell F Brin; Stanley Fahn; Xandra O Breakefield; Laurie J Ozelius; Neil J Risch
The DYT1 phenotype and guidelines for diagnostic testing.
Neurology 2000;54(9):1746-52.
2000: Christine Klein; Nadia Gurvich; Miguel Sena-Esteves; Susan Bressman; Mitchell F Brin; Barbara J Ebersole; S Fink; Lars Forsgren; Jennifer Friedman; D Grimes; Gösta Holmgren; M Kyllerman; Anthony E Lang; Deborah de Leon; Joanne Leung; C Prioleau; Deborah Raymond; G Sanner; Rachel Saunders-Pullman; Peter Vieregge; J Wahlström; Xandra O Breakefield; Patricia L Kramer; Laurie J Ozelius; Stuart C Sealfon
Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia.
Annals of neurology 2000;47(3):369-73.
2000: Pullanipally Shashidharan; Brian C Kramer; Ruth H Walker; C Warren Olanow; Mitchell F Brin
Immunohistochemical localization and distribution of torsinA in normal human and rat brain.
Brain research 2000;853(2):197-206.
2000: Cynthia L Comella; Joseph Jankovic; Mitchell F Brin
Use of botulinum toxin type A in the treatment of cervical dystonia.
Neurology 2000;55(12 Suppl 5):S15-21.
2000: C Warren Olanow; Mitchell F Brin; Jose A Obeso
The role of deep brain stimulation as a surgical treatment for Parkinson's disease.
Neurology 2000;55(12 Suppl 6):S60-6.
1999: Laurie J Ozelius; CE Page; Christine Klein; Jeffrey W Hewett; M Mineta; Joanne Leung; Christo Shalish; Susan Bressman; Deborah de Leon; Mitchell F Brin; Stanley Fahn; David P Corey; Xandra O Breakefield
The TOR1A (DYT1) gene family and its role in early onset torsion dystonia.
Genomics 1999;62(3):377-84.
1999: Allison Brashear; Mark F Lew; D D Dykstra; Cynthia L Comella; Stewart A Factor; Robert L Rodnitzky; R Trosch; Carlos Singer; Mitchell F Brin; JJ Murray; JD Wallace; A Willmer-Hulme; M Koller
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
Neurology 1999;53(7):1439-46.
1999: Mitchell F Brin; Mark F Lew; Charles H Adler; Cynthia L Comella; Stewart A Factor; Joseph Jankovic; C O'Brien; JJ Murray; JD Wallace; A Willmer-Hulme; M Koller
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
Neurology 1999;53(7):1431-8.
1999: Christine Klein; Mitchell F Brin; Patricia L Kramer; Miguel Sena-Esteves; Deborah de Leon; Dana Doheny; Susan Bressman; Stanley Fahn; Xandra O Breakefield; Laurie J Ozelius
Association of a missense change in the D2 dopamine receptor with myoclonus dystonia.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(9):5173-6.
1999: Ruth H Walker; Harry Spiera; Mitchell F Brin; C Warren Olanow
Parkinsonism associated with Sjögren's syndrome: three cases and a review of the literature.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):262-8.
1999: Christine Klein; CE Page; Peter LeWitt; Mark Forrest Gordon; Deborah de Leon; Yasser Awaad; Xandra O Breakefield; Mitchell F Brin; Laurie J Ozelius
Genetic analysis of three patients with an 18p- syndrome and dystonia.
Neurology 1999;52(3):649-51.
1999: Christine Klein; Jennifer Friedman; Susan Bressman; Peter Vieregge; Mitchell F Brin; Peter P Pramstaller; Deborah de Leon; Johann Hagenah; MG Sieberer; C Fleet; Rosemary Kiely; W Xin; Xandra O Breakefield; Laurie J Ozelius; Katherine B Sims
Genetic testing for early-onset torsion dystonia (DYT1): introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects.
Genetic testing 1999;3(4):323-8.
1998: William J Binder; Andrew Blitzer; Mitchell F Brin
Treatment of hyperfunctional lines of the face with botulinum toxin A.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 1998;24(11):1198-205.
1998: Andrew Blitzer; Mitchell F Brin; C F Stewart
Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
The Laryngoscope 1998;108(10):1435-41.
1998: Christine Klein; Mitchell F Brin; Deborah de Leon; Svetlana A Limborska; Irina A Ivanova-Smolenskaya; Susan Bressman; A Friedman; Elena D Markova; Neil J Risch; Xandra O Breakefield; Laurie J Ozelius
De novo mutations (GAG deletion) in the DYT1 gene in two non-Jewish patients with early-onset dystonia.
Human molecular genetics 1998;7(7):1133-6.
1998: Mitchell F Brin; William Koller
Epidemiology and genetics of essential tremor.
Movement disorders : official journal of the Movement Disorder Society 1998;13 Suppl 3():55-63.
1998: Mitchell F Brin; Andrew Blitzer; C Stewart
Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin.
Advances in neurology 1998;78():237-52.
1998: Blair Ford; Paul Greene; Elan D Louis; Susan Bressman; Robert R Goodman; Mitchell F Brin; S Sadiq; Stanley Fahn
Intrathecal baclofen in the treatment of dystonia.
Advances in neurology 1998;78():199-210.
1998: Susan Bressman; Deborah de Leon; Deborah Raymond; Paul Greene; Mitchell F Brin; Stanley Fahn; Laurie J Ozelius; Xandra O Breakefield; Patricia L Kramer; Neil J Risch
The role of the DYT1 gene in secondary dystonia.
Advances in neurology 1998;78():107-15.
1998: Laurie J Ozelius; Jeffrey W Hewett; CE Page; Susan Bressman; Patricia L Kramer; Christo Shalish; Deborah de Leon; Mitchell F Brin; Deborah Raymond; D Jacoby; John B Penney; Neil J Risch; Stanley Fahn; James Gusella; Xandra O Breakefield
The gene (DYT1) for early-onset torsion dystonia encodes a novel protein related to the Clp protease/heat shock family.
Advances in neurology 1998;78():93-105.
1997: Laura A Almasy; Susan Bressman; Deborah Raymond; Patricia L Kramer; Paul Greene; Gary A Heiman; Blair Ford; J Yount; Deborah de Leon; S Chouinard; Rachel Saunders-Pullman; Mitchell F Brin; R P Kapoor; A C Jones; H Shen; Stanley Fahn; Neil J Risch; TG Nygaard
Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families.
Annals of neurology 1997;42(4):670-3.
1997: Mark F Lew; B T Adornato; Drake D Duane; D D Dykstra; Stewart A Factor; J M Massey; Mitchell F Brin; Joseph Jankovic; Robert L Rodnitzky; Carlos Singer; M R Swenson; Daniel Tarsy; JJ Murray; M Koller; JD Wallace
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
Neurology 1997;49(3):701-7.
1997: Laurie J Ozelius; Jeffrey W Hewett; CE Page; Susan Bressman; Patricia L Kramer; Christo Shalish; Deborah de Leon; Mitchell F Brin; Deborah Raymond; David P Corey; Stanley Fahn; Neil J Risch; AJ Buckler; James Gusella; Xandra O Breakefield
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein.
Nature genetics 1997;17(1):40-8.
1997: Susan Bressman; Deborah de Leon; Deborah Raymond; Paul Greene; Mitchell F Brin; Stanley Fahn; Laurie J Ozelius; Xandra O Breakefield; Patricia L Kramer; Neil J Risch
Secondary dystonia and the DYTI gene.
Neurology 1997;48(6):1571-7.
1997: Laurie J Ozelius; Jeffrey W Hewett; Patricia L Kramer; Susan Bressman; Christo Shalish; Deborah de Leon; M Rutter; Neil Risch; Mitchell F Brin; Elena D Markova; Svetlana A Limborska; Irina A Ivanova-Smolenskaya; M K McCormick; Stanley Fahn; AJ Buckler; James Gusella; Xandra O Breakefield
Fine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium.
Genome research 1997;7(5):483-94.
1997: Andrew Blitzer; William J Binder; Jonathan E Aviv; M S Keen; Mitchell F Brin
The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients.
Archives of otolaryngology--head & neck surgery 1997;123(4):389-92.
1997: Andrew Blitzer; Mitchell F Brin
Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1997;116(3):328-30.
1997: C F Stewart; E L Allen; P Tureen; B E Diamond; Andrew Blitzer; Mitchell F Brin
Adductor spasmodic dysphonia: standard evaluation of symptoms and severity.
Journal of voice : official journal of the Voice Foundation 1997;11(1):95-103.
1997: Mitchell F Brin
Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group.
Muscle & nerve. Supplement 1997;6():S208-20.
1997: Mitchell F Brin
Botulinum toxin: chemistry, pharmacology, toxicity, and immunology.
Muscle & nerve. Supplement 1997;6():S146-68.
1996: Blair Ford; P Greene; Elan D Louis; G Petzinger; Susan Bressman; R Goodman; Mitchell F Brin; S Sadiq; Stanley Fahn
Use of intrathecal baclofen in the treatment of patients with dystonia.
Archives of neurology 1996;53(12):1241-6.
1996: Stanley Fahn; Mitchell F Brin; A J Dwork; William J Weiner; Christopher G Goetz; Ali H Rajput
Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma.
Movement disorders : official journal of the Movement Disorder Society 1996;11(3):298-310.
1996: Charles H Adler; Richard S Zimmerman; M K Lyons; F Simeone; Mitchell F Brin
Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease.
Movement disorders : official journal of the Movement Disorder Society 1996;11(1):79-81.
1995: Andrew Blitzer; A Komisar; S Baredes; Mitchell F Brin; C Stewart
Voice failure after tracheoesophageal puncture: management with botulinum toxin.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1995;113(6):668-70.
1995: M F Gordon; Susan Bressman; Mitchell F Brin; Deborah de Leon; D Warburton; K Yeboa; Stanley Fahn
Dystonia in a patient with deletion of 18q.
Movement disorders : official journal of the Movement Disorder Society 1995;10(4):496-9.
1994: Mitchell F Brin; C Stewart; Andrew Blitzer; Beverly E Diamond
Laryngeal botulinum toxin injections for disabling stuttering in adults.
Neurology 1994;44(12):2262-6.
1994: Susan Bressman; Deborah de Leon; Patricia L Kramer; Laurie J Ozelius; Mitchell F Brin; Paul Greene; Stanley Fahn; Xandra O Breakefield; N J Risch
Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation.
Annals of neurology 1994;36(5):771-7.
1994: Susan Bressman; A L Hunt; Gary A Heiman; Mitchell F Brin; Robert E Burke; Stanley Fahn; JM Trugman; Deborah de Leon; Patricia L Kramer; Kirk Wilhelmsen
Exclusion of the DYT1 locus in a non-Jewish family with early-onset dystonia.
Movement disorders : official journal of the Movement Disorder Society 1994;9(6):626-32.
1994: Patricia L Kramer; Gary A Heiman; T Gasser; Laurie J Ozelius; Deborah de Leon; Mitchell F Brin; Robert E Burke; J Hewett; A L Hunt; C Moskowitz
The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews.
American journal of human genetics 1994;55(3):468-75.
1994: Charles H Adler; Lawrence Wrabetz; Mitchell F Brin; Howard I Hurtig
Cerebellar ataxia, dystonia, and tremor within a family: variable phenotypes of a single genetic disorder?
Movement disorders : official journal of the Movement Disorder Society 1994;9(2):155-60.
1994: Susan Bressman; Gary A Heiman; TG Nygaard; Laurie J Ozelius; A L Hunt; Mitchell F Brin; M F Gordon; C B Moskowitz; Deborah de Leon; Robert E Burke
A study of idiopathic torsion dystonia in a non-Jewish family: evidence for genetic heterogeneity.
Neurology 1994;44(2):283-7.
1993: J Borg-Stein; Z M Pine; J R Miller; Mitchell F Brin
Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations.
American journal of physical medicine & rehabilitation / Association of Academic Physiatrists 1993;72(6):364-8.
1993: Andrew Blitzer; Mitchell F Brin; M S Keen; Jonathan E Aviv
Botulinum toxin for the treatment of hyperfunctional lines of the face.
Archives of otolaryngology--head & neck surgery 1993;119(9):1018-22.
1993: G I Hurowitz; J M Silver; Mitchell F Brin; D T Williams; William G Johnson
Neuropsychiatric aspects of adult-onset Tay-Sachs disease: two case reports with several new findings.
The Journal of neuropsychiatry and clinical neurosciences 1993;5(1):30-6.
1992: Laurie J Ozelius; Patricia L Kramer; Deborah de Leon; N Risch; Susan Bressman; D E Schuback; Mitchell F Brin; David J Kwiatkowski; Robert E Burke; James Gusella
Strong allelic association between the torsion dystonia gene (DYT1) andloci on chromosome 9q34 in Ashkenazi Jews.
American journal of human genetics 1992;50(3):619-28.
1992: Andrew Blitzer; Mitchell F Brin; C Stewart; Jonathan E Aviv; Stanley Fahn
Abductor laryngeal dystonia: a series treated with botulinum toxin.
The Laryngoscope 1992;102(2):163-7.
1991: Mitchell F Brin
Interventional neurology: treatment of neurological conditions with local injection of botulinum toxin.
Archivos de neurobiologiá 1991;54(5):173-89.
1991: Dale J Lange; M Rubin; Paul Greene; U J Kang; C B Moskowitz; Mitchell F Brin; R E Lovelace; Stanley Fahn
Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes.
Muscle & nerve 1991;14(7):672-5.
1991: Andrew Blitzer; Mitchell F Brin
Laryngeal dystonia: a series with botulinum toxin therapy.
The Annals of otology, rhinology, and laryngology 1991;100(2):85-9.
1991: David J Kwiatkowski; TG Nygaard; D E Schuback; S Perman; JM Trugman; Susan Bressman; Robert E Burke; Mitchell F Brin; Laurie J Ozelius; Xandra O Breakefield
Identification of a highly polymorphic microsatellite VNTR within the argininosuccinate synthetase locus: exclusion of the dystonia gene on 9q32-34 as the cause of dopa-responsive dystonia in a large kindred.
American journal of human genetics 1991;48(1):121-8.
1991: Mitchell F Brin
Interventional neurology: treatment of neurological conditions with local injection of botulinum toxin.
Archivos de neurobiologiá 1991;54 Suppl 3():7-23.
1990: N J Risch; Susan Bressman; D DeLeon; Mitchell F Brin; Robert E Burke; Paul Greene; H Shale; Elizabeth B Claus; L A Cupples; Stanley Fahn
Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance.
American journal of human genetics 1990;46(3):533-8.
1990: Patricia L Kramer; Deborah de Leon; Laurie J Ozelius; N Risch; Susan Bressman; Mitchell F Brin; D E Schuback; Robert E Burke; David J Kwiatkowski; H Shale
Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34.
Annals of neurology 1990;27(2):114-20.
1989: Susan Bressman; Deborah de Leon; Mitchell F Brin; N Risch; Robert E Burke; Paul Greene; H Shale; Stanley Fahn
Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance.
Annals of neurology 1989;26(5):612-20.
1989: Laurie J Ozelius; Patricia L Kramer; C B Moskowitz; David J Kwiatkowski; Mitchell F Brin; Susan Bressman; D E Schuback; Catherine T Falk; N Risch; Deborah de Leon
Human gene for torsion dystonia located on chromosome 9q32-q34.
Neuron 1989;2(5):1427-34.
1989: Andrew Blitzer; Mitchell F Brin; Paul Greene; Stanley Fahn
Botulinum toxin injection for the treatment of oromandibular dystonia.
The Annals of otology, rhinology, and laryngology 1989;98(2):93-7.
1989: Mitchell F Brin; Andrew Blitzer; Stanley Fahn; W Gould; R E Lovelace
Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
Movement disorders : official journal of the Movement Disorder Society 1989;4(4):287-96.
1988: Mitchell F Brin; DS Younger
Neurologic disorders and aspiration.
Otolaryngologic clinics of North America 1988;21(4):691-9.
1988: Andrew Blitzer; Mitchell F Brin; Stanley Fahn; R E Lovelace
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia).
The Laryngoscope 1988;98(2):193-7.
1988: Mitchell F Brin; Stanley Fahn; C Moskowitz; A Friedman; H M Shale; Paul Greene; Andrew Blitzer; T List; D Lange; R E Lovelace
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Advances in neurology 1988;50():599-608.
1988: Susan Bressman; Deborah de Leon; Mitchell F Brin; N Risch; H Shale; Robert E Burke; Paul Greene; Stanley Fahn
Inheritance of idiopathic torsion dystonia among Ashkenazi Jews.
Advances in neurology 1988;50():45-56.
1988: Patricia L Kramer; Laurie J Ozelius; Mitchell F Brin; Stanley Fahn; Kenneth K Kidd; James Gusella; X O Breakefield
Molecular genetics of an autosomal dominant form of torsion dystonia.
Advances in neurology 1988;50():57-66.
1988: Mitchell F Brin; C Moskowitz; Stanley Fahn
Dystonia clinical research center tissue resource facility: investigations on collected tissue.
Advances in neurology 1988;50():215-22.
1988: Dale J Lange; Mitchell F Brin; Stanley Fahn; R E Lovelace
Distant effects of locally injected botulinum toxin: incidence and course.
Advances in neurology 1988;50():609-13.
1987: Dale J Lange; Mitchell F Brin; C L Warner; Stanley Fahn; R E Lovelace
Distant effects of local injection of botulinum toxin.
Muscle & nerve 1987;10(6):552-5.
1987: Mitchell F Brin; Stanley Fahn; C Moskowitz; A Friedman; H M Shale; Paul Greene; Andrew Blitzer; T List; D Lange; R E Lovelace
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Movement disorders : official journal of the Movement Disorder Society 1987;2(4):237-54.
1986: Andrew Blitzer; Mitchell F Brin; Stanley Fahn; D Lange; R E Lovelace
Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias.
The Laryngoscope 1986;96(11):1300-1.
1986: X O Breakefield; Susan Bressman; Patricia L Kramer; Laurie J Ozelius; C Moskowitz; Rudolph E Tanzi; Mitchell F Brin; W Hobbs; D Kaufman; A Tobin
Linkage analysis in a family with dominantly inherited torsion dystonia: exclusion of the pro-opiomelanocortin and glutamic acid decarboxylase genes and other chromosomal regions using DNA polymorphisms.
Journal of neurogenetics 1986;3(3):159-75.
1986: Robert E Burke; Mitchell F Brin; Stanley Fahn; Susan Bressman; C Moskowitz
Analysis of the clinical course of non-Jewish, autosomal dominant torsion dystonia.
Movement disorders : official journal of the Movement Disorder Society 1986;1(3):163-78.